Momentum Continues with Additions to IP, Life Sciences Practices
BOSTON, Mass. - March 3, 2008 – Goodwin Procter today announced that Ginger R. Dreger, Paul L. Davis and Nancy W. Vensko have joined the firm’s Intellectual Property Practice Group. The three attorneys will be located in the firm’s Palo Alto office. Since establishing its first California office in April 2006, 85 attorneys have joined Goodwin Procter in the state, 29 of whom are based in the firm’s Palo Alto office, which opened in June 2007.
Dreger was a member of Heller Ehrman’s Patents & Trademarks Practice Group, where she headed the life sciences patent prosecution practice. Her largest client, Genentech, is the world’s largest biotech company by market capitalization, and Dreger has had a long-standing relationship with the company. She also represents other emerging and public biotech companies in Silicon Valley and other parts of the country. Davis, who has over 25 years of experience working with technology companies in Silicon Valley, joins from Heller Ehrman, where he served as chair of its Patents & Trademarks Practice Group. Vensko, a former managing partner at the San Luis Obispo office of Knobbe, Martens, Olson & Bear, has experience in patent prosecution, interference and opposition practice, and provides strategic advice about patent portfolios in the biotechnology area.
“These new lawyers are a significant addition for Goodwin Procter’s Life Sciences and IP Practices and the firm overall,” said Regina M. Pisa, chairman and managing partner. “Our attorneys specialize in sophisticated intellectual property work, and we pride ourselves on successfully protecting and defending intellectual property rights, which safeguards the future for companies on both a national and global scale, as potentially billions of dollars are at stake.”
“Goodwin Procter has been aggressively expanding throughout California,” said Kathy A. Fields, co-chair of the firm’s Palo Alto office. “Ginger, Paul and Nancy offer practical business experience combined with in-depth legal knowledge to our roster of Silicon Valley clients.”
Goodwin Procter’s core group of life sciences lawyers has expertise in corporate law, FDA counseling, strategic alliances and intellectual property law. The attorneys blend legal acumen, deep industry experience and scientific capabilities across all biological, chemical and medical technologies.
Goodwin Procter’s national IP group has been ranked by IP Law & Business as one of the nation’s most active intellectual property law firms. The firm provides counsel in all aspects of intellectual property, including patent litigation, due diligence, deal structuring, licensing, outsourcing and related transactions, patent counseling and portfolio development, and privacy and data security.
Goodwin Procter’s patent and intellectual property litigation expertise has grown tremendously over the last several years. Currently, the firm has approximately 70 full time patent litigators, approximately 30 of whom are partners, with a similar number doing IP licensing and transactional work. There are also 20 lawyers dedicated to opinion work, as well as seven science advisors. In addition, Goodwin Procter has over 20 Ph.D.s, primarily in the chemical, biotechnology, medical and electrical areas, to do patent prosecution and support litigation and opinion writing. The firm’s team includes 56 attorneys and science advisors who are registered to practice before the U.S. Patent & Trademark Office. Goodwin Procter has represented clients in nearly every important patent venue in the United States, including Delaware, the various districts in Texas, California, New Jersey, and Massachusetts.
About Goodwin Procter
Goodwin Procter LLP is one of the nation’s leading law firms with more than 850 attorneys in offices in Boston, Los Angeles, New York, Palo Alto, San Diego, San Francisco, and Washington, D.C. The firm’s core areas of practice are corporate, litigation and real estate, with specialized areas of focus that include financial services, private equity, technology, REITs and real estate capital markets, intellectual property and products liability. Information may be found at www.goodwinprocter.com.
Ginger R. Dreger was a member of Heller Ehrman’s Patents & Trademarks Practice Group, where she headed the life sciences patent prosecution practice in the firm’s Silicon Valley office. Prior to that, Dreger was a partner at Knobbe, Martens, Olson & Bear LLP. Previously, she served as Chief Patent Counsel for Scios, Inc., a Sunnyvale-based biotech company, and Section Patent Counsel for Genentech. Dreger focuses her practice in the biotech space and her work involves client counseling and strategic advice in domestic and international patent matters, including worldwide patent protection strategies, freedom to operate issues, IP due diligence and opinions. She is admitted to practice in California and before the U.S. Patent and Trademark Office.
Paul L. Davis served as chair of Heller Ehrman’s Patents & Trademarks Practice Group. He has over 25 years of industry experience working with technology companies in Silicon Valley. Previously, Davis headed the patent group at Wilson Sonsini Goodrich & Rosati. Prior to that, he co-founded Haynes & Davis, a boutique specializing in intellectual property. Davis focuses his practice in the medical device, electrical engineering, photonics, networking, e-commerce and telecommunication industries, and his work involves U.S. and international phase patent prosecution and strategic counseling services. He also has significant experience litigating intellectual property issues for information technology companies. Davis is admitted to practice in California and before the U.S. Patent and Trademark Office.
Nancy W. Vensko was previously the managing partner in Knobbe, Martens, Olson & Bear’s San Luis Obispo office. While at Knobbe, Martens, Olson & Bear, she served as the project director for its patent services contract with the National Institutes of Health. Vensko has experience in patent prosecution, interference and opposition practice, and providing strategic advice about patent portfolios in the biotechnology area. Previously, she was in-house patent counsel at Amylin Pharmaceuticals, Inc. in San Diego. Vensko is admitted to practice in California and before the U.S. Patent and Trademark Office.